Last reviewed · How we verify
LipoCol Forte
At a glance
| Generic name | LipoCol Forte |
|---|---|
| Sponsor | National Taiwan University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Red Yeast Rice for Primary Prevention of Hypercholesterolemia
- The Pharmacokinetic Study of Red Yeast Rice Capsule Compared to Lovastatin Tablet in Healthy Subjects (PHASE4)
- Pharmacokinetic and Drug Interaction Study of Red Yeast Rice Capsules (PHASE4)
- The Effect of LipoCol Forte® Capsules on the Pharmacokinetics of Nifedipine After Administering Single-dose Combination to Healthy Subjects (PHASE4)
- Lovastatin and Its ß-hydroxy Acid From Four 600 mg LipoCol Forte® Capsules Compared to That of One 20 mg Mevacor® Tablet in Healthy Subjects (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LipoCol Forte CI brief — competitive landscape report
- LipoCol Forte updates RSS · CI watch RSS
- National Taiwan University Hospital portfolio CI